Asthmatics May Be Breathing Easier Soon
01
October

By Adem Lewis / in , , , , , , , , , , , , /


I’m Gabe Garza with today’s health news. According
to a press release issued by the American Thoracic Society, a new study found a way
to administer a nanoparticle-based gene therapy that repairs lungs damaged by chronic allergic
asthma and reduces the inflammation that causes asthma attacks. Asthma causes inflammation
and narrowing of the airways, which causes coughing, wheezing, shortness of breath and
chest tightness. For this study, researchers had four groups of female lab mice. One group
was given an allergen while the was the control group. The next day, researchers gave the
mice either one dose of saline, one dose of DNA particles or three doses of DNA particles.
After 20 days, researchers found that the one dose group had reduced lung inflammation
and improved airways structure. Researchers are now hoping to move into Phase I trials
in the near future to better understand mechanisms of this therapy. For more information visit
dailyrx.com


Leave a Reply

Your email address will not be published. Required fields are marked *